1-20 of 35
Nikolai Podoltsev
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of the international working group (IWG) 2023 criteria for clinical benefit in higher risk Myelodysplastic Syndromes (HR-MDS) using a large, international, randomized Phase 3 clinical trial dataset

Free
Maximilian Stahl, Jan Philipp Bewersdorf, Rahul Vedula, Yiwen Liu, H. Moses Murdock, Harrison Tsai, Evan Chen, Benjamin Rolles, Nikolai Podoltsev, Lourdes Mendez, Luca Lanino, Alain Mina, Luis E. Aguirre, Mikkael Sekeres, Lionel Ades, R. Coleman Lindsley, Amer Zeidan
Journal: Blood
Blood (2025) 146 (Supplement 1): 5651.
https://doi.org/10.1182/blood-2025-5651
Published: 2025
Journal Articles

Menin inhibitors for NPM1-mutated and KMT2A-rearranged relapsed/refractory acute myeloid leukemia (AML): A systematic review and meta-analysis

Free
Konan Beke, Abdulrahman Alhajahjeh, Alyssa Grimshaw, Nikolai Podoltsev, Lourdes Mendez, Maximilian Stahl, Amer Zeidan, Jan Philipp Bewersdorf
Journal: Blood
Blood (2025) 146 (Supplement 1): 5154.
https://doi.org/10.1182/blood-2025-5154
Published: 2025
Journal Articles

Clonal persistence and early cooperative mutations shape transformation in myelofibrosis

Free
Noushin Farnoud, Kamal Menghrajani, Paola Guglielmelli, Christopher Famulare, Erin McGovern, Giuseppe Gaetano Loscocco, Andriy Derkach, Andrew Dunbar, Naseema Gangat, Vikas Gupta, Andrea Arruda, Taghi Manshouri, Srdan Verstovsek, Andrew Kuykendall, Vincent Ho, Auro Viswabandya, Joachim Deeg, Thomas Monahan, Tania Jain, Jeanne Palmer, Alla Keyzner, Aaron Gerds, Alexandra Gomez-Arteaga, Nikolai Podoltsev, Roni Tamari, Helen Ajufo, Satyajit Kosuri, Haris Ali, Idoroenyi Amanam, Jordan Chervin, Minal Patel, Jesús Gutiérrez-Abril, Sarun Sereewattanawoot, Juan Arango Ossa, Francesco Passamonti, Francesco Maura, Maymona Abdelmagid, Ahmed Abdelrheem, Yassin Bashir, Muhammad Yousuf, Animesh Pardanani, Kapila Viges, David Shoultz, Rick Winneker, Omar Abdel-Wahab, John Mascarenhas, Ronald Hoffman, Ross Levine, Elli Papaemmanuil, Alessandro Vannucchi, Ayalew Tefferi, Raajit Rampal
Journal: Blood
Blood (2025) 146 (Supplement 1): 2046.
https://doi.org/10.1182/blood-2025-2046
Published: 2025
Journal Articles

Phase II Results of ECOG-ACRIN EA9152: A multicenter study of liposomal vincristine (L-VCR) or vincristine sulfate (VCR) and venetoclax (VEN) in relapsed or refractory acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL)

Free
Neil Palmisiano, Juwhei Lee, David Claxton, Elisabeth Paietta, Nikolai Podoltsev, Jae Park, Dale Schaar, Jonathan Webster, Selina Luger, Mark Litzow
Journal: Blood
Blood (2025) 146 (Supplement 1): 1577.
https://doi.org/10.1182/blood-2025-1577
Published: 2025
Journal Articles

Impact of therapy delays on outcomes in adults with BCR::ABL1 negative b-lineage acute lymphoblastic leukemia (ALL) in the ECOG-ACRIN E1910 trial randomized to conventional chemotherapy +/- blinatumomab

Free
Bhavana Bhatnagar, Zhuoxin Sun, Ryan Mattison, Elisabeth Paietta, Yanming Zhang, Janis Racevskis, Hillard Lazarus, Jacob Rowe, Daniel Arber, Matthew Wieduwilt, Michaela Liedtke, Julie Bergeron, Brent Wood, Keith Pratz, Shira Dinner, Noelle Frey, Steven Gore, Ehab Atallah, Geoffrey Uy, Deepa Jeyakumar, Tara Lin, Cheryl Willman, Nikolai Podoltsev, Daniel Deangelo, Shejal Patel, Michelle Elliott, Anjali Advani, Dimitrios Tzachanis, Pankit Vachhani, Rupali Roy, Elad Sharon, Richard Little, Harry Erba, Richard Stone, Selina Luger, Charles Mullighan, Martin Tallman, Mark Litzow
Journal: Blood
Blood (2025) 146 (Supplement 1): 1549.
https://doi.org/10.1182/blood-2025-1549
Published: 2025
Journal Articles

Early discharge program cost savings for patients with newly diagnosed acute myeloid leukemia after intensive induction chemotherapy

Free
Cameron Hunter, Karthik Chetlapalli, Satoko Ito, Jan Philipp Bewersdorf, Prajwal Boddu, Sabrina Browning, Stephanie Halene, Terri Parker, Scott Huntington, Shalin Kothari, Lourdes Mendez, Natalia Neparidze, Tarsheen Sethi, Maximilian Stahl, Nikolai Podoltsev, Amer Zeidan, Rory Shallis, George Goshua
Journal: Blood
Blood (2025) 146 (Supplement 1): 6208.
https://doi.org/10.1182/blood-2025-6208
Published: 2025
Journal Articles

Treatment initiation and first line tyrosine kinase inhibitor (TKI) selection for older patients with newly diagnosed chronic myeloid leukemia (CML) in the United States (US) before and after the introduction of generic imatinib (GE-IMA)

Free
Rong Wang, Jessica Stempel, Rory Shallis, Jan Philipp Bewersdorf, Lourdes Mendez, Maximilian Stahl, Amer Zeidan, Xiaomei Ma, Nikolai Podoltsev
Journal: Blood
Blood (2025) 146 (Supplement 1): 6393.
https://doi.org/10.1182/blood-2025-6393
Published: 2025
Journal Articles

Impact of metformin on the incidence of thrombotic events in ­older patients with polycythemia vera and essential thrombocythemia in the United States

Free
Jessica Stempel, Rong Wang, Rory Shallis, Lourdes Mendez, Jan Philipp Bewersdorf, Maximilian Stahl, Amer Zeidan, Xiaomei Ma, Nikolai Podoltsev
Journal: Blood
Blood (2025) 146 (Supplement 1): 6392.
https://doi.org/10.1182/blood-2025-6392
Published: 2025
Journal Articles

Genomic determinants of treatment outcome and identification of a new genomic subset of adult acute lymphoblastic leukemia from the ECOG-ACRIN E1910 randomized phase III trial

Free
Xiaoming Zhong, Kathryn Roberts, Lindsey Montefiori, Zhuoxin Sun, Huimei Wei, Petri Polonen, Ti-Cheng Chang, Wenchao Zhang, Shaohua Lei, Evadnie Rampersaud, Yiping Fan, Gang Wu, Ryan Mattison, Yanming Zhang, Janis Racevskis, Hillard Lazarus, Jacob Rowe, Daniel Arber, Matthew Wieduwilt, Michaela Liedtke, Julie Bergeron, Brent Wood, Keith Pratz, Shira Dinner, Noelle Frey, Steven Gore, Bhavana Bhatnagar, Ehab Atallah, Geoffrey Uy, Deepa Jeyakumar, Tara Lin, Cheryl Willman, Nikolai Podoltsev, Daniel Deangelo, Shejal Patel, Michelle Elliott, Anjali Advani, Dimitrios Tzachanis, Pankit Vachhani, Rupali Roy, Elad Sharon, Richard Little, Harry Erba, Richard Stone, Martin Tallman, Jun J. Yang, Elisabeth Paietta, Selina Luger, Mark Litzow, Charles Mullighan
Journal: Blood
Blood (2025) 146 (Supplement 1): 31.
https://doi.org/10.1182/blood-2025-31
Published: 2025
Journal Articles

Clinical characteristics, disease progression, and vascular events in essential thrombocythemia: A single-center cohort study with long-term follow-up.

Free
Daniil Katkov, Lourdes Mendez, Nikolai Podoltsev, Max Stahl, Amer Zeidan, Jan Philipp Bewersdorf
Journal: Blood
Blood (2025) 146 (Supplement 1): 7322.
https://doi.org/10.1182/blood-2025-7322
Published: 2025
Journal Articles

Clinical, cytogenetic and molecular predictors of early mortality in acute promyelocytic leukemia (APL): Real-world analysis

Free
Aram Bidikian, Amer Al-Musa, Cameron Hunter, Lourdes Mendez, Nikolai Podoltsev, Maximilian Stahl, Amer Zeidan, Rory Shallis, Jan Philipp Bewersdorf
Journal: Blood
Blood (2025) 146 (Supplement 1): 5160.
https://doi.org/10.1182/blood-2025-5160
Published: 2025
Journal Articles

Prospective evaluation of an AI-powered clinical trial patient matching (CTPM) system in myelodysplastic syndromes (MDS) and multiple myeloma

Free
Cristian Taborda, Guannan Gong, Gabriella Douglas, Jessica Liu, Abel Incoom, Maximilian Stahl, Nikolai Podoltsev, Jan Philipp Bewersdorf, Theodore Getz, Jessica Stempel, Tariq Kewan, Luca Lanino, Aram Bidikian, Terri Parker, Noffar Bar, Sabrina Browning, Stephanie Halene, Natalia Neparidze, Amer Zeidan, Lourdes Mendez
Journal: Blood
Blood (2025) 146 (Supplement 1): 1086.
https://doi.org/10.1182/blood-2025-1086
Published: 2025
Journal Articles

Trial in progress: A phase I study evaluating the safety of cirtuvivint (CIRT) as monotherapy and in combination with ASTX727 in patients with myelodysplastic syndromes (MDS) and Acute Myeloid Leukemia (AML)

Free
Evan Chen, Yiwen Liu, Eytan Stein, Brian Ball, Ivana Gojo, Olatoyosi Odenike, Neil Palmisiano, Vu Duong, Zimu Gong, Michael Hochman, Carine Bossard, John Hill, Mirta Grifman, Daniel Deangelo, Richard Stone, Ilene Galinsky, Rebecca Leonard, Richard Little, Steven Gore, Jan Philipp Bewersdorf, Lourdes Mendez, Nikolai Podoltsev, Amer Zeidan, Omar Abdel-Wahab, Maximilian Stahl
Journal: Blood
Blood (2025) 146 (Supplement 1): 3431.
https://doi.org/10.1182/blood-2025-3431
Published: 2025
Journal Articles

The combination of ruxolitinib and the CDK4/6 inhibitor abemaciclib demonstrates safety and efficacy in previously treated myelofibrosis patients: Results of A phase I study

Free
Jan Philipp Bewersdorf, Andriy Derkach, Amer Zeidan, Emily Burton, Katherine Kan, Marissa Giuliani, Jeetayu Biswas, Michael Mauro, Brian Chernak, Tamanna Haque, Nikolai Podoltsev, Ross Levine, Prithviraj Bose, Raajit Rampal
Journal: Blood
Blood (2025) 146 (Supplement 1): 3814.
https://doi.org/10.1182/blood-2025-3814
Published: 2025
Journal Articles

Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations

Free
Michelle Worst, Heather Friedman, Sarah Bomba, Megan Whitney, Davecia Cameron, Stephanie Baumhover, Sanneke Koekkoek, Deb Middleton, Charlotte Warren, Yoji Yamaguchi, Haleh Kadkhoda, Nikolai Podoltsev
Journal: Blood
Blood (2025) 146 (Supplement 1): 8223.
https://doi.org/10.1182/blood-2025-8223
Published: 2025
Journal Articles

Large language models mediated extraction of clinical information from bone marrow biopsy pathology reports

Free
Luca Lanino, Theodore Getz, Tariq Kewan, Ahmad Kiwan, Benjamin Rolles, Aram Bidikian, Nurefsan Sariipek, Lourdes Mendez, Nikolai Podoltsev, Thomas Durant, Daniella Meeker, Sudhir Perincheri, Peter Gershkovich, Samuel Katz, Alexa Siddon, Mina Xu, Jan Philipp Bewersdorf, Matteo Della Porta, Amer Zeidan, Maximilian Stahl
Journal: Blood
Blood (2025) 146 (Supplement 1): 2555.
https://doi.org/10.1182/blood-2025-2555
Published: 2025
Journal Articles

Tuscany Study demonstrates safety and efficacy of tuspetinib plus standard of care venetoclax and azacitidine in patients with newly diagnosed AML ineligible for induction chemotherapy

Free
Gabriel Mannis, Nikolai Podoltsev, Deepa Jeyakumar, Justin Watts, Pankit Vachhani, Brian Jonas, Uma Borate, Eric Tam, Harry Erba, Yuling Shi, Donna Haney, William Rice, Rafael Bejar, Naval Daver
Journal: Blood
Blood (2025) 146 (Supplement 1): 1645.
https://doi.org/10.1182/blood-2025-1645
Published: 2025
Journal Articles

Acute myeloid leukemia (AML) after myeloproliferative neoplasm (MPN): Real-world outcomes in the new AML treatment era

Free
Jan Philipp Bewersdorf, Rong Wang, Lourdes Mendez, Max Stahl, Amer Zeidan, Xiaomei Ma, Nikolai Podoltsev
Journal: Blood
Blood (2025) 146 (Supplement 1): 721.
https://doi.org/10.1182/blood-2025-721
Published: 2025
Journal Articles

Toxicities on the E1910 phase III randomized trial of blinatumomab plus chemotherapy in adults with BCR:ABL-1 negative acute lymphoblastic leukemia

Free
Anjali Advani, Li Chen, Zhuoxin Sun, Ryan Mattison, Elisabeth Paietta, Yanming Zhang, Janis Racevskis, Hillard Lazarus, Jacob Rowe, Dan Arber, Matthew Wieduwilt, Michaela Liedtke, Julie Bergeron, Brent Wood, Keith Pratz, Shira Dinner, Noelle Frey, Steven Gore, Bhavana Bhatnagar, Ehab Atallah, Geoffrey Uy, Deepa Jeyakumar, Tara Lin, Cheryl Willman, Nikolai Podoltsev, Daniel Deangelo, Shejal Patel, Michelle Elliott, Dimitrios Tzachanis, Pankit Vachhani, Rupali Bhave, Elad Sharon, Richard Little, Harry Erba, Richard Stone, Selina Luger, Charles Mullighan, Martin Tallman, Mark Litzow
Journal: Blood
Blood (2025) 146 (Supplement 1): 5120.
https://doi.org/10.1182/blood-2025-5120
Published: 2025
Journal Articles

Pacritinib in patients with high-risk myelofibrosis: Outcomes from post-hoc analyses of two Phase 3 studies

Free
Pankit Vachhani, Nikolai Podoltsev, Ashwin Kishtagari, Purvi Suthar, Michael Vredenburg, Karisse Roman-Torres, Aaron Gerds
Journal: Blood
Blood (2025) 146 (Supplement 1): 2019.
https://doi.org/10.1182/blood-2025-2019
Published: 2025